Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer.

Autor: Furusawa, Takashi, Cavero, Renzo, Liu, Yue, Li, Haojian, Xu, Xia, Andresson, Thorkell, Reinhold, William, White, Olivia, Boufraqech, Myriem, Meyer, Thomas J., Hartmann, Oliver, Diefenbacher, Markus E., Pommier, Yves, Weyemi, Urbain
Zdroj: Molecular Carcinogenesis; Jun2024, Vol. 63 Issue 6, p1024-1037, 14p
Databáze: Complementary Index
Externí odkaz: